Top

Published in:

01-09-2009 | Translational Research and Biomarkers

Comprehensive Analysis of the Clinical Significance of Inducing Pluripotent Stemness-Related Gene Expression in Colorectal Cancer Cells

Authors: Yasumitsu Saiki, MD, Shinya Ishimaru, MD, PhD, Koshi Mimori, MD, PhD, Yasushi Takatsuno, MD, Makoto Nagahara, MD, Hideshi Ishii, MD, PhD, Kazutaka Yamada, MD, Masaki Mori, MD, PhD, FACS

Published in: Annals of Surgical Oncology | Issue 9/2009

Abstract

Background

We previously determined that cancer stem-like cells may influence the susceptibility of colorectal cancer (CRC) cells to chemotherapeutic agents. Although Takahashi and Park identified a set of induced pluripotent stem cell (iPS)-related genes required for normal stem cell maintenance, the precise role of iPS-related gene expression in CRC pathogenesis remains to be determined. The purpose of this study was to clarify the clinical relevance of “stemness”-regulating gene expression in CRC cases.

Materials and methods

Cancer cells were excised from tissues of 79 CRC cases by laser microdissection (LMD), and quantitative RT-PCR was used to evaluate expression levels of the iPS-related genes c-MYC, SOX2, OCT3/4, LIN28, KLF4, and NANOG, and to identify any associations between their expression and clinicopathological CRC progression.

Results

We found that LIN28 expression is significantly associated with lymph node metastasis (p = 0.018) and Dukes stage (p = 0.0319). SOX2expression is also correlated with lymph node metastasis. Furthermore, the ten cases with Dukes D disease expressed significantly higher levels of SOX2transcript than the other 69 cases (p = 0.0136). In contrast, KLF4 expression was inversely related to Dukes stage. Expression of c-MYC, OCT3/4, and NANOG did not appear to have clinical relevance in CRC cases.

Conclusion

The present analysis strongly suggests that altered expression of several iPS-related genes plays a role in CRC pathogenesis.

Grothey A, Sargent DJ. FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer. J Clin Oncol. 2005;23:3311–3.PubMedCrossRef

Marshall J. The role of bevacizumab as first-line therapy for colon cancer. Semin Oncol. 2005;32:S43–7.PubMedCrossRef

Haraguchi N, Utsunomiya T, Inoue H, et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells Dayton, Ohio. 2006;24:506–13.CrossRef

Ieta K, Tanaka F, Haraguchi N, et al. Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol. 2008;15:638–48.PubMedCrossRef

Park IH, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451:141–6.PubMedCrossRef

Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–72.PubMedCrossRef

Takahashi K, Yamanaka S Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.PubMedCrossRef

Chen Y, Shi L, Zhang L, et al. The molecular mechanism governing the oncogenic potential of sox2 in breast cancer. J Biol Chem. 2008;283:17969–78.PubMedCrossRef

Ezeh UI, Turek PJ, Reijo RA, Clark AT. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer. 2005;104:2255–65.PubMedCrossRef

10.

Looijenga LH, Stoop H, de Leeuw HP, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003;63:2244–50.PubMed

11.

Ohnishi S, Ohnami S, Laub F, et al. Downregulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem Biophys Res Commun. 2003;308:251–6.PubMedCrossRef

12.

Phi JH, Park SH, Kim SK, et al. Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway. Am J Surg Pathol. 2008;32:103–12.PubMedCrossRef

13.

Wang P, Branch DR, Bali M, Schultz GA, Goss PE, Jin T The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells. Biochem J. 2003;375:199–205.PubMedCrossRef

14.

Okita K, Ichisaka T, Yamanaka S Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448:313–7.PubMedCrossRef

15.

Rody A, Karn T, Ruckhaeberle E, et al. Differentially expressed genes of reprogrammed human pluripotent stem cells in breast cancer. Eur J Cancer. 2008;44:1789–92.PubMedCrossRef

16.

Mimori K, Kataoka A, Yoshinaga K, et al. Identification of molecular markers for metastasis-related genes in primary breast cancer cells. Clin Exp Met. 2005;22:59–67.CrossRef

17.

Mori M, Mimori K, Yoshikawa Y, et al. Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery. 2002;131:S39–47.PubMedCrossRef

18.

Viswanathan SR, Daley GQ, Gregory RI. Selective blockade of microRNA processing by Lin28. Science. 2008;320:97–100.PubMedCrossRef

19.

Park ET, Gum JR, Kakar S, Kwon SW, Deng G, Kim YS. Aberrant expression of SOX2 upregulates MUC5AC gastric foveolar mucin in mucinous cancers of the colorectum and related lesions. Int J Cancer. 2008;122:1253–60.PubMedCrossRef

20.

Xu J, Lu B, Xu F, et al. Dynamic down-regulation of Kruppel-like factor 4 in colorectal adenoma-carcinoma sequence. J Cancer Res Clin Oncol. 2008;134:891–8.PubMedCrossRef

21.

Richards M, Tan SP, Tan JH, Chan WK, Bongso A. The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells (Dayton, Ohio). 2004;22:51–64.PubMedCrossRef

22.

Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917–20.PubMedCrossRef

23.

Dangi-Garimella S, Yun J, Eves EM, et al. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J. 2009;28:347–58.PubMedCrossRef

24.

Bussing I, Slack FJ, Grosshans H. let-7 microRNAs in development, stem cells and cancer. Trends Mol Med. 2008;14:400–9.PubMedCrossRef

25.

Katz JP, Perreault N, Goldstein BG, et al. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology. 2005;128:935–45.PubMedCrossRef

26.

Wei D, Kanai M, Huang S, Xie K Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis. 2006;27:23–31.PubMedCrossRef

27.

Choi BJ, Cho YG, Song JW, et al. Altered expression of the KLF4 in colorectal cancers. Pathol Res Pract. 2006;202:585–9.PubMedCrossRef

28.

Pandya AY, Talley LI, Frost AR, et al. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin Cancer Res. 2004;10:2709–19.PubMedCrossRef

29.

Rowland BD, Peeper DS. KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer. 2006;6:11–23.PubMedCrossRef

30.

Mori M, Barnard GF, Staniunas RJ, Jessup JM, Steele GD, Jr., Chen LB. Prothymosin-alpha mRNA expression correlates with that of c-myc in human colon cancer. Oncogene. 1993;8:2821–6.PubMed

31.

Barker N, van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–7.PubMedCrossRef

Title: Comprehensive Analysis of the Clinical Significance of Inducing Pluripotent Stemness-Related Gene Expression in Colorectal Cancer Cells
Authors: Yasumitsu Saiki, MD
Shinya Ishimaru, MD, PhD
Koshi Mimori, MD, PhD
Yasushi Takatsuno, MD
Makoto Nagahara, MD
Hideshi Ishii, MD, PhD
Kazutaka Yamada, MD
Masaki Mori, MD, PhD, FACS
Publication date: 01-09-2009
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 9/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-009-0567-5

ACC 2024 Congress

Springer Medicine

Comprehensive Analysis of the Clinical Significance of Inducing Pluripotent Stemness-Related Gene Expression in Colorectal Cancer Cells

Abstract

Background

Materials and methods

Results

Conclusion

ACC 2024 Congress

Springer Medicine

Abstract

Background

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 9/2009

Chemotherapy-Associated Hepatotoxicity: Do We Need to Be Concerned?

Response to Letter to the Editor: Isolated Tumor Cells in Sentinel Lymph Nodes and Clinical Implications for Early Breast Cancer

T Cell Infiltrate Predicts Long-Term Survival Following Resection of Colorectal Cancer Liver Metastases

Liver Resection for Metastatic Colorectal Cancer in the Presence of Extrahepatic Disease

CT Versus Intraoperative Peritoneal Cancer Index in Colorectal Cancer Peritoneal Carcinomatosis: Importance of the Difference Between Statistical Significance and Clinical Relevance

Chemosensitivity and Survival in Gastric Cancer Patients with Microsatellite Instability